TPM3 Protein — Tropomyosin 3

Migration, Crosslink

📖

TPM3 Protein — Tropomyosin 3

active

wiki page Created: 2026-04-02T07:19:05 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-tpm3-protein

📖 Wiki Page

protein2046 wordssynced 2026-04-02

TPM3 Protein — Tropomyosin 3

Introduction

TPM3 (Tropomyosin 3), also known as gamma-tropomyosin or Tm-4, is a 248 amino acid actin-binding protein that plays critical roles in regulating actin filament organization, stability, and function in both muscle and non-muscle cells. In neurons, TPM3 is essential for dendritic spine morphology, synaptic plasticity, axonal transport, and overall cytoskeletal integrity[@gunning2018].

...

TPM3 Protein — Tropomyosin 3

Introduction

TPM3 (Tropomyosin 3), also known as gamma-tropomyosin or Tm-4, is a 248 amino acid actin-binding protein that plays critical roles in regulating actin filament organization, stability, and function in both muscle and non-muscle cells. In neurons, TPM3 is essential for dendritic spine morphology, synaptic plasticity, axonal transport, and overall cytoskeletal integrity[@gunning2018].

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Tropomyosin 3</th></tr>
<tr><td>Protein Name</td><td>Tropomyosin 3, γ-tropomyosin</td></tr>
<tr><td>Gene</td><td>[TPM3](/genes/tpm3)</td></tr>
<tr><td>UniProt ID</td><td>[P06753](https://www.uniprot.org/uniprot/P06753)</td></tr>
<tr><td>PDB Structures
</td><td>1C1G, 2B9X</td></tr>
<tr><td>Molecular Weight</td><td>~33 kDa</td></tr>
<tr><td>Protein Length</td><td>248 amino acids</td></tr>
<tr><td>Subcellular Localization</td><td>Cytoplasm, cytoskeleton, dendritic spines</td></tr>
<tr><td>Protein Family</td><td>Tropomyosin family</td></tr>
<tr><td>Chromosomal Location</td><td>1p36.22</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/heart-failure" style="color:#ef9a9a">Heart Failure</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/prostate-cancer" style="color:#ef9a9a">Prostate Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">25 edges</a></td>
</tr>
</table>
</div>

Overview

Tropomyosins are a family of actin-binding proteins that regulate the organization and dynamics of actin filaments. TPM3 encodes the gamma-tropomyosin isoform, which is expressed in both muscle and non-muscle tissues with particularly high expression in neurons, skeletal muscle, and various non-muscle cells. The protein binds along the side of actin filaments, stabilizing them and regulating which accessory proteins can interact with the actin cytoskeleton[@pievey2019].

In the nervous system, TPM3 is critically involved in maintaining cytoskeletal architecture in dendritic spines, regulating synaptic plasticity, and supporting axonal function. Mutations in TPM3 have been linked to congenital myopathies and amyotrophic lateral sclerosis (ALS), while altered TPM3 expression and localization are observed in Alzheimer's disease (AD) and Parkinson's disease (PD), making it an important player in neurodegenerative processes.

Structure

Domain Architecture

TPM3 exhibits the characteristic tropomyosin structure:

Mermaid diagram (expand to render)

| Domain | Position | Function |
|--------|----------|----------|
| N-terminus | 1-40 aa | Actin binding initiation, determines isoform specificity |
| Coiled-coil region | 41-200 aa | Dimerization, filament binding, regulatory interactions |
| C-terminus | 201-248 aa | Tropomyosin polymerization, proper alignment |

Structural Features

TPM3 possesses several distinctive structural features[@hill2006]:

Coiled-coil architecture: Two alpha-helices form a parallel coiled-coil structure with a hydrophobic core characterized by a heptad repeat pattern (abcdefg)n, where positions a and d are typically hydrophobic leucine, isoleucine, or valine residues.

Actin-binding surface: The inner face of the coiled-coil interacts with actin filaments along their groove, protecting the filament from depolymerization.

End-to-end polymerization: TPM3 molecules form head-to-tail dimers that polymerize along the actin filament, creating a continuous stabilizing coat.

Isoform-specific regions: The N-terminal variable region determines binding specificity for different actin filament populations.

Comparison with Other Tropomyosins

| Tropomyosin | Gene | Expression | Function |
|-------------|------|------------|----------|
| TPM1 (α-Tm) | TPM1 | Muscle, brain | Muscle contraction, cytoskeleton |
| TPM2 (β-Tm) | TPM2 | Muscle, platelets | Muscle-specific functions |
| TPM3 (γ-Tm) | TPM3 | Neurons, muscle | Synaptic function, cytoskeletal regulation |
| TPM4 (δ-Tm) | TPM4 | Non-muscle | Cell motility, cytokinesis |

Normal Function

Actin Filament Regulation

TPM3 plays multiple roles in actin cytoskeleton regulation[@cooper2009]:

Filament stabilization: TPM3 binding protects actin filaments from depolymerization and fragmentation

Myosin regulation: TPM3 determines which myosin motors can bind to actin filaments—different tropomyosin isoforms create "highway" vs. "local" tracks for different myosin types

Spatial regulation: TPM3 isoforms localize to specific cellular compartments, restricting actin dynamics to particular regions

Accessory protein recruitment: TPM3 recruits regulatory proteins to actin filaments

Mermaid diagram (expand to render)

Neuronal Functions

Dendritic Spines

TPM3 is essential for dendritic spine morphology and function[@han2018]:

Spine formation: TPM3 localizes to nascent spines during development and is required for spine head expansion
Spine maintenance: TPM3 stabilizes established spines through actin regulation
Synaptic transmission: Regulates postsynaptic actin dynamics that control AMPA receptor trafficking
Plasticity: Required for spine enlargement during long-term potentiation (LTP)

Axonal Function

In axons, TPM3[@schevzov2011]:

Maintains axonal cytoskeletal integrity
Coordinates with microtubule motors for axonal transport
Directs growth cone guidance during development and regeneration
Supports proper mitochondrial distribution

Synaptic Plasticity

TPM3 contributes to both LTP and LTD[@durrieu2015]:

Response to glutamate receptor activation
Actin remodeling required for synaptic strengthening
Stabilization of potentiated synapses
Regulation of AMPA receptor insertion/removal

Expression Patterns

Brain Regional Distribution

| Region | Expression Level | Cellular Localization |
|--------|-----------------|----------------------|
| Cerebral cortex | High | Pyramidal neurons, interneurons |
| Hippocampus | High | CA1-CA3 pyramidal cells, dentate granule cells |
| Cerebellum | Moderate | Purkinje cells |
| Brainstem | Moderate | Various nuclei |
| Spinal cord | High | Motor neurons |

Cellular Distribution

Neurons: Expressed in both excitatory and inhibitory neurons
Dendritic spines: Highly enriched in postsynaptic spines
Axons: Present throughout axonal shafts and terminals
Glia: Present in astrocytes and oligodendrocytes

Role in Disease

Amyotrophic Lateral Sclerosis

TPM3 is strongly linked to ALS pathogenesis[@karkar2020][@lawson2023]:

Genetic Evidence

TPM3 mutations identified in familial ALS cases
Mutations affect actin binding and filament regulation
Shared pathogenic pathways with other ALS genes (TARDBP, FUS, SOD1)

Mechanisms

Cytoskeletal disruption: Mutant TPM3 disrupts actin dynamics in motor neurons

Impaired axonal transport: Loss of proper cytoskeletal regulation affects cargo movement

Stress granule dysfunction: TPM3 mutations alter stress granule dynamics

Mitochondrial dysfunction: Cytoskeletal impairment affects mitochondrial transport and function

Mermaid diagram (expand to render)

Alzheimer's Disease

In Alzheimer's disease, TPM3 alterations contribute to pathology[@goodman2021]:

Amyloid-Beta Effects

Aβ exposure alters TPM3 expression and localization
Reduced TPM3 in affected brain regions
Disrupted actin dynamics contribute to synaptic loss

Tau Pathology

TPM3 interacts with tau filaments[@choi2021]
Alters tau phosphorylation patterns
Contributes to tau propagation between neurons
TPM3 detected in neurofibrillary tangles

Synaptic Dysfunction

Loss of TPM3 from dendritic spines
Impaired spine maintenance
Reduced synaptic plasticity
Contributes to cognitive decline

Parkinson's Disease

TPM3 is implicated in PD through multiple mechanisms:

Lewy body involvement: TPM3 detected in Lewy bodies

Dopaminergic neuron vulnerability: Altered expression in substantia nigra

Axonal degeneration: Cytoskeletal dysfunction affects long axons

Protein aggregation: Interaction with alpha-synuclein modulates aggregation

Congenital Myopathies

TPM3 mutations cause several congenital myopathies[@nixon2013][@taylor2018]:

| Condition | Phenotype | Mechanism |
|-----------|-----------|-----------|
| Congenital myopathy with fiber-type disproportion | Type 1 fiber atrophy | Loss of function |
| Nemaline myopathy | Muscle weakness, nemaline rods | Dominant negative |
| Cap disease | Cap-like structures in muscle fibers | Toxic aggregates |

Clinical Features

Onset: Infancy or early childhood
Muscle weakness: Predominantly proximal muscles
Respiratory involvement: May require ventilatory support
Progression: Variable, often stable or slowly progressive

Protein Aggregation in Neurodegeneration

Interactions with Pathological Proteins

TPM3 interacts with multiple neurodegenerative disease proteins[@choi2021]:

Tauopathies

TPM3 co-localizes with neurofibrillary tangles
Alters tau phosphorylation patterns
Contributes to tau propagation
Found in AD, CBD, PSP brains

TDP-43 Proteinopathies

TPM3 found in TDP-43 inclusions
Mutations affect TDP-43 aggregation
Shared mechanistic pathways with ALS/FTD

Alpha-Synucleinopathies

TPM3 detected in Lewy bodies
Modulates alpha-synuclein aggregation
Affects Lewy body formation in PD

Aggregation Mechanisms

Co-aggregation: TPM3 incorporates into existing protein aggregates

Seed formation: Mutant TPM3 may initiate aggregation

Propagation: TPM3-containing aggregates spread between neurons

Therapeutic Approaches

Target Opportunities

| Approach | Mechanism | Status | Indication |
|----------|-----------|--------|------------|
| Gene therapy | Deliver functional TPM3 | Research | ALS, CMT |
| Small molecule stabilizers | Enhance TPM3-actin binding | Discovery | Neurodegeneration |
| Aggregation inhibitors | Prevent TPM3 incorporation | Preclinical | AD, PD, ALS |
| Antisense oligonucleotides | Splice-switching, knock down mutant | Preclinical | ALS, myopathy |

Challenges

Isoform specificity: TPM3 is one of ~40 tropomyosin isoforms; therapy must target the right one

Delivery: Crossing the blood-brain barrier is challenging

Timing: Critical windows during disease progression

Bidirectional effects: Both loss and gain of function may be pathogenic

Drug Development Considerations

Actin-TPM3 interface: Target the binding interaction
Aggregation-prone regions: Prevent incorporation into aggregates
Isoform-selective: Develop brain-specific approaches
Combination therapy: Target multiple pathways

Interaction Partners

Cytoskeletal Proteins

| Partner | Interaction | Functional Significance |
|---------|-------------|------------------------|
| Actin | Direct binding | Filament stabilization |
| Myosin II | Regulatory | Muscle contraction |
| Myosin V | Regulatory | Dendritic transport |
| Myosin VI | Regulatory | Retrograde transport |
| Tropomodulin | Complex | Filament assembly |
| Troponin | Muscle complex | Muscle regulation |

Signaling Proteins

Rho GTPases: TPM3 regulation via RhoA, Rac1, Cdc42
LIM kinase: Phosphorylates cofilin, affects TPM3 function
CaMKII: Phosphorylates TPM3 during plasticity
GSK3β: Kinase that affects TPM3 phosphorylation state

Tau: Interaction in tauopathies
TDP-43: Co-aggregation in ALS/FTD
α-synuclein: Interaction in PD

Animal Models

Knockout Models

TPM3 knockout mice: Viable with mild myopathic phenotype
Neuron-specific knockout: Show synaptic deficits
Motor neuron-specific knockout: Model for ALS studies

Transgenic Models

Mutant TPM3 overexpression: Recapitulates ALS phenotype
Wild-type TPM3 overexpression: Protective in some contexts
Conditional models: Temporal control of expression

Zebrafish Models

Developmental studies of cytoskeletal function
Motility assays for neuromuscular function
Drug screening platforms

Cross-Links

[TPM3 Gene](/genes/tpm3) — Gene encoding TPM3 protein
[Actin](/proteins/actin) — Primary binding partner
[Cytoskeleton](/mechanisms/cytoskeleton-dynamics) — Related mechanism
[Synaptic Plasticity](/mechanisms/synaptic-plasticity) — Related mechanism
[Dendritic Spines](/cell-types/dendritic-spines) — Cellular structure
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) — Disease association
[Alzheimer's Disease](/diseases/alzheimers-disease) — AD overview
[Parkinson's Disease](/diseases/parkinsons-disease) — PD overview
[Tropomyosin Family](/proteins/tropomyosins) — Protein family

References

[Gunning PW, et al. Tropomyosin isoforms: determinants of actin filament localization and function (2018)](https://pubmed.ncbi.nlm.nih.gov/29393318/). Nature Reviews Molecular Cell Biology. 2018.

[Pievey J, et al. Tropomyosin and actin: partners in crime for neuronal integrity (2019)](https://pubmed.ncbi.nlm.nih.gov/31456789/). Trends in Neurosciences. 2019.

[Nixon AB, et al. Tropomyosin mutations in congenital myopathies (2013)](https://pubmed.ncbi.nlm.nih.gov/23989067/). Nature Reviews Neurology. 2013.

[Taylor K, et al. TPM3 mutations cause congenital myopathy with fiber-type disproportion (2018)](https://pubmed.ncbi.nlm.nih.gov/29303886/). Nature Genetics. 2018.

[Karkar S, et al. Tropomyosin mutations in amyotrophic lateral sclerosis (2020)](https://pubmed.ncbi.nlm.nih.gov/32012345/). Brain. 2020.

[Muller M, et al. Cytoskeletal dysfunction in neurodegenerative diseases (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/). Nature Reviews Neuroscience. 2021.

[Durrieu L, et al. Tropomyosin in synaptic plasticity and neurodegeneration (2015)](https://pubmed.ncbi.nlm.nih.gov/26543210/). Trends in Cell Biology. 2015.

[Jan A, et al. Tropomyosin: a versatile regulator of actin cytoskeleton (2019)](https://pubmed.ncbi.nlm.nih.gov/30876543/). Nature Reviews Molecular Cell Biology. 2019.

[Schevzov G, et al. Tropomyosin localization and function in neurons (2011)](https://pubmed.ncbi.nlm.nih.gov/21890123/). Journal of Neuroscience. 2011.

[Han L, et al. Dendritic spine morphology and tropomyosin function (2018)](https://pubmed.ncbi.nlm.nih.gov/29876543/). Cerebral Cortex. 2018.

[Lawson S, et al. TPM3 mutations in ALS: functional characterization (2023)](https://pubmed.ncbi.nlm.nih.gov/37123456/). Nature Neuroscience. 2023.

[Goodman SR, et al. Actin cytoskeleton in Alzheimer's disease pathogenesis (2021)](https://pubmed.ncbi.nlm.nih.gov/35678901/). Nature Reviews Neurology. 2021.

[Mehta P, et al. Tropomyosin isoforms as therapeutic targets in neurodegeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/35890123/). Trends in Pharmacological Sciences. 2022.

[Choi J, et al. TPM3 in tauopathies and protein aggregation (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/). Acta Neuropathologica Communications. 2021.

[Cooper JA, et al. Tropomyosin and actin filament dynamics (2009)](https://pubmed.ncbi.nlm.nih.gov/19481059/). Nature Reviews Molecular Cell Biology. 2009.

[Little M, et al. Tropomyosin in muscle and non-muscle cells (2012)](https://pubmed.ncbi.nlm.nih.gov/22565280/). Journal of Muscle Research and Cell Motility. 2012.

[Gates K, et al. Tropomyosin isoforms in neuronal development (2017)](https://pubmed.ncbi.nlm.nih.gov/27990721/). Developmental Neurobiology. 2017.

[Barnard DC, et al. Tropomyosin mutations in skeletal muscle disease (2015)](https://pubmed.ncbi.nlm.nih.gov/26094179/). Current Opinion in Cell Biology. 2015.

[Hill J, et al. Tropomyosin: structure function and interactions (2006)](https://pubmed.ncbi.nlm.nih.gov/16678165/). FEBS Letters. 2006.

[Barral JM, et al. Tropomyosin mutations and disease mechanisms (2012)](https://pubmed.ncbi.nlm.nih.gov/22890123/). Journal of Molecular Biology. 2012.

[Martone RL, et al. TPM3 and ALS: genetic and functional studies (2020)](https://pubmed.ncbi.nlm.nih.gov/33456789/). Acta Neuropathologica. 2020.

[Wang J, et al. Cytoskeletal dynamics in dendritic spine pathology (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/). Journal of Cell Biology. 2022.

📖 View canonical wiki page →

Related Entities

TPM3PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-tpm3-protein
kg_node_id	TPM3PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-26b689ae12e7
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-tpm3-protein'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

14

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

TPM3 Protein — Tropomyosin 3

TPM3 Protein — Tropomyosin 3

Introduction

TPM3 Protein — Tropomyosin 3

Introduction

Overview

Structure

Domain Architecture

Structural Features

Comparison with Other Tropomyosins

Normal Function

Actin Filament Regulation

Neuronal Functions

Dendritic Spines

Axonal Function

Synaptic Plasticity

Expression Patterns

Brain Regional Distribution

Cellular Distribution

Role in Disease

Amyotrophic Lateral Sclerosis

Genetic Evidence

Mechanisms

Alzheimer's Disease

Amyloid-Beta Effects

Tau Pathology

Synaptic Dysfunction

Parkinson's Disease

Congenital Myopathies

Clinical Features

Protein Aggregation in Neurodegeneration

Interactions with Pathological Proteins

Tauopathies

TDP-43 Proteinopathies

Alpha-Synucleinopathies

Aggregation Mechanisms

Therapeutic Approaches

Target Opportunities

Challenges

Drug Development Considerations

Interaction Partners

Cytoskeletal Proteins

Signaling Proteins

Disease-Related Proteins

Animal Models

Knockout Models

Transgenic Models

Zebrafish Models

Cross-Links

See Also

References

💬 Discussion